PlainRecalls
FDA Drug Critical Class I Terminated

Atropine Sulfate Injection Solution, 0.4 mg/1 mL (0.4 mg/mL), in a) 1 mL syringes and b) 2 mL syringes, Rx Only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-010-45, UPC: 0100352533010453

Reported: July 13, 2016 Initiated: August 21, 2015 #D-1153-2016

Product Description

Atropine Sulfate Injection Solution, 0.4 mg/1 mL (0.4 mg/mL), in a) 1 mL syringes and b) 2 mL syringes, Rx Only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-010-45, UPC: 0100352533010453

Reason for Recall

Subpotent Drug

Details

Recalling Firm
Cantrell Drug Company
Units Affected
a) 450 syringes and b) 1250 syringes
Distribution
Nationwide
Location
Little Rock, AR

Frequently Asked Questions

What product was recalled?
Atropine Sulfate Injection Solution, 0.4 mg/1 mL (0.4 mg/mL), in a) 1 mL syringes and b) 2 mL syringes, Rx Only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-010-45, UPC: 0100352533010453. Recalled by Cantrell Drug Company. Units affected: a) 450 syringes and b) 1250 syringes.
Why was this product recalled?
Subpotent Drug
Which agency issued this recall?
This recall was issued by the FDA Drug on July 13, 2016. Severity: Critical. Recall number: D-1153-2016.